Question: Should the BCG vaccine be given universally to all neonates at birth in a population with high prevalence for HIV to mitigate the risk of severe TB disease or should vaccination be delayed until HIV status is known?
- Population: Neonates in a population with high prevalence of HIV
- Intervention: One dose of BCG vaccine given at birth.
- Comparison(s): Delaying BCG vaccination.
- Outcome: Prevention of severe TB disease
- Evidence to recommendation table